Milestone Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MIST and other ETFs, options, and stocks.About MIST
Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that is designed as a rapid-onset nasal spray to be self-administered by patients.
CEOJoseph G. Oliveto
CEOJoseph G. Oliveto
Employees33
Employees33
HeadquartersMontréal, Québec
HeadquartersMontréal, Québec
Founded2003
Founded2003
Employees33
Employees33
MIST Key Statistics
Market cap82.87M
Market cap82.87M
Price-Earnings ratio-1.88
Price-Earnings ratio-1.88
Dividend yield—
Dividend yield—
Average volume3.00M
Average volume3.00M
High today$3.07
High today$3.07
Low today$1.46
Low today$1.46
Open price$1.76
Open price$1.76
Volume21.24M
Volume21.24M
52 Week high$3.07
52 Week high$3.07
52 Week low$0.6254
52 Week low$0.6254
MIST News
TipRanks 10h
Milestone prices $52.5M common shares offering at $1.50 per shareMilestone Pharmaceuticals (MIST) announced the pricing of its previously announced underwritten public offering of (i) 31.5M of its common shares, accompanying...
People also own
Based on the portfolios of people who own MIST. This list is generated using Robinhood data, and it’s not a recommendation.